Hartland & Co »

Ovid Therapeutics shares owned by Hartland & Co

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Hartland & Co

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.5k 2.7k 1.63

More positions owned by Hartland & Co

Vanguard Index Fds Put Put Option (Principal) (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Value Etf (VTV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Nvidia Corporation Put Put Option (Principal) (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Hartland & Co

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Affinity Asset Advisors
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Point72 Asset Management
Vanguard Group
Saturn V Capital Management
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management

View all funds holding Ovid Therapeutics